Publications:189
Video Visit Available
Accepting New Patients
Book an Appointment
About Me
Dr. Ryan Ungaro is an Associate Professor of Medicine in the Division of Gastroenterology at the Icahn School of Medicine at Mount Sinai. Dr. Ungaro received his medical degree from the Icahn School of Medicine at Mount Sinai where he graduated Alpha Omega Alpha and with Distinction in Research. He completed his internal medicine training and served as chief resident at the Mount Sinai Medical Center then went on to complete fellowship training in gastroenterology at the Mount Sinai Medical Center and served as chief gastroenterology fellow. Dr. Ungaro received training in translational inflammatory bowel disease (IBD) research as a Howard Hughes Medical Institute Research Fellow and completed a Masters in Biostatistics and Clinical Research Methods at Columbia University Mailman School of Public Health.
Dr. Ungaro specializes in the care of patients with ulcerative colitis and Crohn's disease. He is Director of the Comprehensive Care for the Recently Diagnosed IBD Patient (COMPASS-IBD) Program at the Susan and Leonard Feinstein IBD Clinical Center. This program provides interdisciplinary care for recently diagnosed IBD patients. His research focuses on understanding early IBD including the impact of early intervention on IBD outcomes and precision medicine approaches to improve risk stratification and optimization of therapy for recently diagnosed IBD patients. His research has been supported by an NIH K23 Career Development Award and a Crohn's and Colitis Foundation Career Development Award.
In addition, Dr. Ungaro is co-founder of the Surveillance Epidemiology of Coronavirus Under Research Exclusion (SECURE-IBD) web-based registry. SECURE-IBD is an international collaboration that has been recognized as a leading source of data to guide IBD management in the COVID-19 era.
Dr. Ungaro has also served on the American Gastroenterological Association (AGA) Research Awards Panel and as Co-Chair of the Crohn's and Colitis Foundation Rising Educators Academics and Clinicians Helping IBD (REACH-IBD) committee. He has received various distinctions including being selected for the AGA Future Leaders Program, the Eric R. Lemmer Memorial Award, the Crohn’s and Colitis Foundation Greater New York Chapter Take Steps Health Care Honored Hero, and the Cullman Family Award for Excellence in Physician Communication.
Language
Position
Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Morningside
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
Research Topics
Inflammatory Bowel Disease (IBD)
About Me
Dr. Ryan Ungaro is an Associate Professor of Medicine in the Division of Gastroenterology at the Icahn School of Medicine at Mount Sinai. Dr. Ungaro received his medical degree from the Icahn School of Medicine at Mount Sinai where he graduated Alpha Omega Alpha and with Distinction in Research. He completed his internal medicine training and served as chief resident at the Mount Sinai Medical Center then went on to complete fellowship training in gastroenterology at the Mount Sinai Medical Center and served as chief gastroenterology fellow. Dr. Ungaro received training in translational inflammatory bowel disease (IBD) research as a Howard Hughes Medical Institute Research Fellow and completed a Masters in Biostatistics and Clinical Research Methods at Columbia University Mailman School of Public Health.
Dr. Ungaro specializes in the care of patients with ulcerative colitis and Crohn's disease. He is Director of the Comprehensive Care for the Recently Diagnosed IBD Patient (COMPASS-IBD) Program at the Susan and Leonard Feinstein IBD Clinical Center. This program provides interdisciplinary care for recently diagnosed IBD patients. His research focuses on understanding early IBD including the impact of early intervention on IBD outcomes and precision medicine approaches to improve risk stratification and optimization of therapy for recently diagnosed IBD patients. His research has been supported by an NIH K23 Career Development Award and a Crohn's and Colitis Foundation Career Development Award.
In addition, Dr. Ungaro is co-founder of the Surveillance Epidemiology of Coronavirus Under Research Exclusion (SECURE-IBD) web-based registry. SECURE-IBD is an international collaboration that has been recognized as a leading source of data to guide IBD management in the COVID-19 era.
Dr. Ungaro has also served on the American Gastroenterological Association (AGA) Research Awards Panel and as Co-Chair of the Crohn's and Colitis Foundation Rising Educators Academics and Clinicians Helping IBD (REACH-IBD) committee. He has received various distinctions including being selected for the AGA Future Leaders Program, the Eric R. Lemmer Memorial Award, the Crohn’s and Colitis Foundation Greater New York Chapter Take Steps Health Care Honored Hero, and the Cullman Family Award for Excellence in Physician Communication.
Language
Position
Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Morningside
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
Research Topics
Inflammatory Bowel Disease (IBD)
Clinical Focus
- Antibiotic-Associated Colitis-C Difficile
- Celiac Disease
- Colon Polyps
- Crohn's Disease
- Gastroenterology
- Inflammatory Bowel Disease
- Ulcerative Colitis
Video
Education
MD, Icahn School of Medicine at Mount Sinai
MS, Columbia University Mailman School of Public Health
Residency, Internal Medicine
Mount Sinai Hospital
Fellowship, Gastroenterology
Mount Sinai Hospital
Certifications
American Board of Internal Medicine
Awards
2018
Icahn School of Medicine at Mount sinai Immunotherapy Fellowship
2018
New York Super Doctors Rising Stars
2018
American Gastroenterological Association Future Leaders Program
2016
Mount Sinai Department of Medicine Advisory Board Award
2016
Eric R. Lemmer Memorial Award
Mount Sinai Division of Gastroenterology
2016
Mount Sinai KL2 Scholars Awards for Clinical and translational Research Career Development Awards
2016
Poster of Distinctions, Crohn's and Colitis Foundation Advances in Inflammatory Bowel Disease Conference
2015
Distinguished Poster Award
New York Society for Gastrointestinal Endoscopy (NYSGE) Annual Course
2015
National GI Jeopardy Competition Champion
American College of Gastroenterology (ACG)
2014
Burrill B. Crohn Research Foundation Research Grant
2014
Best Abstract Award
Mount Sinai Department of Medicine Research Day
2012
The Silver Apple Teaching Award
Mount Sinai Internal Medicine Residency
2009
Mount Sinai Distinction in Research Award
2009
Mount Sinai Milton C. Engel Prize in Geriatric Medicine
2008
Alpha Omega Alpha (AOA)
2004
Phi Beta Kappa
Locations
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
Patients with Cigna Medicare Advantage or Humana Medicare Advantage insurance: Please read this important message before booking to find out if out-of-network costs may apply to your next visit.
- Feinstein IBD Clinical Center17 East 102nd Street, 5th Floor, New York, NY, 10029
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- A Simple Endoscopic Score for Crohn's Disease (SES-CD) ≥ 7 Predicts Disease Progression. Jellyana Peraza, Marco Emilio Kaper, Andre Bargas, Iris Kim, Manasi Agrawal, Lone Larsen, Henrik Albaek Jacobsen, Tine Jess, Jean Frederic Colombel, Joana Torres, Ryan C. Ungaro, Ashwin N. Ananthakrishnan. Alimentary Pharmacology and Therapeutics
- High Serum Pesticide Levels Are Associated With Increased Odds of Inflammatory Bowel Disease in a Nested Case-Control Study. Manasi Agrawal, Ryan C. Ungaro, Palak Rajauria, Jared Magee, Lauren Petrick, Vishal Midya. Gastroenterology
- Ustekinumab Drug Clearance Is Better Associated with Disease Control than Serum Trough Concentrations in a Prospective Cohort of Inflammatory Bowel Disease †. Andres J. Yarur, Thierry Dervieux, Ryan Ungaro, Elizabeth A. Spencer, Alexandra Bruss, Lizbeth Nunez, Brandon Berens, Séverine Vermeire, Zhigang Wang, John C. Panetta, Erwin Dreesen, Marla C. Dubinsky. Pharmaceutics
Patient Experience Star Ratings and Comments
The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai provider communicated with them during an office visit. The Star Rating is based on patient responses to three questions on a patient experience survey, a standardized questionnaire sent to verified patients and distributed by a third party vendor, Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Ungaro has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Ungaro has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.